Back to Search
SAMERA KHAN
Speech-Language Assistant
NPI: 1255624466Individual
Specialties, Licenses & Credentials
Speech-Language AssistantPrimary
Specialist/Technologist — Speech-Language Assistant
Code: 2355S0801X
34771(TX)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (3)
Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study.
PMID 24500308·Nephrol Dial Transplant·2014
3-trial
Cost effectiveness of paricalcitol versus cinacalcet with low-dose vitamin D for management of secondary hyperparathyroidism in haemodialysis patients in the USA.
PMID 24214232·Clin Drug Investig·2014
3-trial
Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study.
PMID 22387567·Nephrol Dial Transplant·2012
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 14090 SOUTHWEST FWY, SUITE 300
SUGAR LAND, TX 77478 - Phone
- (281) 746-3053
Quick Facts
- NPI
- 1255624466
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 3
Are you this provider?
Claim Your Profile